Overall survival of patients with metastatic breast cancer in Sweden: a nationwide studyAntonis Valachis, Henrik Lindman, P. Carlqvist et al.|British Journal of Cancer|2022Cited by 52
Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registryAntonios Valachis, Henrik Lindman, P. Carlqvist et al.|Acta Oncologica|2021Cited by 21
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi studyJürgen Geisler, Sophie Yammeni, Peeter Karihtala et al.|Acta Oncologica|2023Cited by 6
Abstract P1-16-10: Treatment patterns and outcomes of different subtypes of metastatic breast cancer patients in a Swedish real world setting with a focus on HER2-/HR+ subtypeHenrik Lindman, Barbro Holm, Máté Szilcz et al.|Cancer Research|2019Cited by 2
Abstract P2-08-03: Machine learning to identify and characterize metastatic breast cancer patients in Sweden: A population-based study. CLEE011ASE01Henrik Lindman, Barbro Holm, Máté Szilcz et al.|Cancer Research|2020Cited by 0